Evidence map›Paper›PMID 34450729›Full record

ArticleSensors (Basel, Switzerland)2021

Detection of Diabetic Eye Disease from Retinal Images Using a Deep Learning Based CenterNet Model.

Tahira Nazir, Marriam Nawaz, Junaid Rashid, Rabbia Mahum, Momina Masood, Awais Mehmood, Farooq Ali, Jungeun Kim, Hyuk-Yoon Kwon, Amir Hussain

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Recognition of diabetic retinopathy and macular edema using deep learning.Medical & biological engineering & computing · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tahira NazirDepartment of Computer Science, University of Engineering and Technology Taxila, Taxila 47050, Pakistan.ORCID 0000-0001-8130-3721
Marriam NawazDepartment of Computer Science, University of Engineering and Technology Taxila, Taxila 47050, Pakistan.
Junaid RashidDepartment of Computer Science and Engineering, Kongju National University, Gongju 31080, Chungcheongnam-do, Korea.ORCID 0000-0002-1485-0757
Rabbia MahumDepartment of Computer Science, University of Engineering and Technology Taxila, Taxila 47050, Pakistan.
Momina MasoodDepartment of Computer Science, University of Engineering and Technology Taxila, Taxila 47050, Pakistan.
Awais MehmoodDepartment of Computer Science, University of Engineering and Technology Taxila, Taxila 47050, Pakistan.
Farooq AliDepartment of Computer Science, University of Engineering and Technology Taxila, Taxila 47050, Pakistan.
Jungeun KimDepartment of Computer Science and Engineering, Kongju National University, Gongju 31080, Chungcheongnam-do, Korea.
Hyuk-Yoon KwonResearch Center for Electrical and Information Technology, Department of Industrial Engineering, Seoul National University of Science and Technology, Seoul 01811, Korea.ORCID 0000-0002-1125-6533
Amir HussainCentre of AI and Data Science, Edinburgh Napier University, Edinburgh EH11 4DY, UK.ORCID 0000-0002-8080-082X

Funding

National Research Foundation of Korea 2021R1F1A1064050)
6 · The paper itself

Abstract

Diabetic retinopathy (DR) is an eye disease that alters the blood vessels of a person suffering from diabetes. Diabetic macular edema (DME) occurs when DR affects the macula, which causes fluid accumulation in the macula. Efficient screening systems require experts to manually analyze images to recognize diseases. However, due to the challenging nature of the screening method and lack of trained human resources, devising effective screening-oriented treatment is an expensive task. Automated systems are trying to cope with these challenges; however, these methods do not generalize well to multiple diseases and real-world scenarios. To solve the aforementioned issues, we propose a new method comprising two main steps. The first involves dataset preparation and feature extraction and the other relates to improving a custom deep learning based CenterNet model trained for eye disease classification. Initially, we generate annotations for suspected samples to locate the precise region of interest, while the other part of the proposed solution trains the Center Net model over annotated images. Specifically, we use DenseNet-100 as a feature extraction method on which the one-stage detector, CenterNet, is employed to localize and classify the disease lesions. We evaluated our method over challenging datasets, namely, APTOS-2019 and IDRiD, and attained average accuracy of 97.93% and 98.10%, respectively. We also performed cross-dataset validation with benchmark EYEPACS and Diaretdb1 datasets. Both qualitative and quantitative results demonstrate that our proposed approach outperforms state-of-the-art methods due to more effective localization power of CenterNet, as it can easily recognize small lesions and deal with over-fitted training data. Our proposed framework is proficient in correctly locating and classifying disease lesions. In comparison to existing DR and DME classification approaches, our method can extract representative key points from low-intensity and noisy images and accurately classify them. Hence our approach can play an important role in automated detection and recognition of DR and DME lesions.

Indexed as

Deep LearningDiabetes MellitusDiabetic RetinopathyMacular EdemaHumansdeep learningdiabetic macular edemadiabetic retinopathymedical imagingretinal images

Identifiers

PMID34450729
PMCPMC8398326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.